Bengaluru, June 11 -- During Wednesday's trading session, shares of a pharmaceutical company involved in manufacturing and selling tablets, capsules, and other healthcare products jumped nearly 17.3 percent on NSE, after announcing H2 FY25 financial results with a rise in net profit by 72 percent HoH and 187 percent YoY.

With a market capitalisation of Rs. 89 crores, at 02:08 p.m., shares of Accretion Pharmaceuticals Limited were trading in the green at Rs. 79.9 on NSE, up by 14.5 percent, as against its previous closing price of Rs. 69.8.

What's the News: According to the latest regulatory filings on the NSE, Accretion Pharmaceuticals Limited announced the financial results for H2 FY25 on Tuesday after market hours.

For H2 FY25, Accre...